Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.75 |
| ▸ | MPO | P05164 | 6/20 | 0.73 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.73 |
| ▸ | TEAD4 | Q15561 | 2/20 | 0.71 |
| ▸ | YAP1 | P46937 | 1/20 | 0.71 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.71 |
| ▸ | TAS2R14 | Q9NYV8 | 5/20 | 0.69 |
| ▸ | AURKA | O14965 | 1/20 | 0.69 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.69 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.68 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.68 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | GMNN | O75496 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TTR | P02766 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flufenamic Acid SCHEMBL29356958 | 1.00 | RXFP1 (0.75) | RXFP1MPOGRIK1TEAD4YAP1 | |
| Flufenamic Acid SCHEMBL11524554 | 0.99 | RXFP1 (0.73) | RXFP1MPOGRIK1TEAD4YAP1 | |
| Flufenamic Acid SCHEMBL9845499 | 0.99 | RXFP1 (0.73) | RXFP1MPOGRIK1TEAD4YAP1 | |
| SCHEMBL8416271 | 0.92 | RXFP1 (0.81) | RXFP1MPOGRIK1 | |
| Flufenamic Acid SCHEMBL10531046 | 0.89 | MPO (0.67) | RXFP1MPOGRIK1TEAD4YAP1 | |
| SCHEMBL19002050 | 0.89 | TAS2R14 (0.62) | RXFP1MPOGRIK1TEAD4YAP1 | |
| SCHEMBL11330727 | 0.88 | TAS2R14 (0.82) | RXFP1MPOGRIK1TAS2R14AKR1C3 | |
| SCHEMBL19657901 | 0.87 | RXFP1 (0.70) | RXFP1MPOGRIK1TEAD4YAP1 | |
| SCHEMBL9522037 | 0.87 | YAP1 (0.74) | RXFP1MPOGRIK1TEAD4YAP1 | |
| SCHEMBL12851592 | 0.87 | RXFP1 (0.78) | RXFP1MPOTEAD4YAP1TEAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 36258 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| CN-122056860-A | Application of flufenamic acid in preparation of polymyxin E antibacterial synergist | 新疆农垦科学院 | 2026-05-19 | — | — | CN | claimed |
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260115192-A1 | PHARMACEUTICAL COMPOSITIONS | SHENZHEN PHARMACIN CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-12605432-B2 | Combinations for antigen based therapy | DIAMYD MEDICAL AB (SE) | 2026-04-21 | — | — | US | claimed |
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | claimed |
| US-12545750-B2 | Method for the diimide hydrogenation of emulsified unsaturated polymers | PARKER DANE K (US) | 2026-02-10 | — | — | US | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-0040899-A2 | Method of delivering drug with aid of effervescent activity generated in environment of use | ALZA CORPORATION (US) | 1981-12-02 | — | — | EP | claimed |
| EP-0039051-A2 | Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1981-11-04 | — | — | EP | claimed |
| US-4272529-A | ANTIINFLAMMATORY | SIMES S.P.A. (IT) | 1981-06-09 | — | — | US | claimed |
| US-4260613-A | ANTIINFLAMMATORY, ANTIPYRETIC, ANALGESIC | CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A. (IT) | 1981-04-07 | — | — | US | claimed |
| US-4247554-A | ADMINISTERING A QUINAZOLINONE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-01-27 | — | — | US | claimed |
| EP-0016460-A1 | Salicylamide esters having therapeutical activity, process for their preparation and related pharmaceutical composition | NEOPHARMED S.p.A. (IT) | 1980-10-01 | — | — | EP | claimed |
| US-4198431-A | ANTIINFLAMMATORY | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1980-04-15 | — | — | US | claimed |
| US-4123534-A | VIGILANCE INCREASING AGENTS | Wulfing, Johann W. (DE) | 1978-10-31 | — | — | US | claimed |
| US-4091095-A | DIALKYLPHOSPHINYL-ALKYL ESTER OF A 2-(ARYL-AMINO) BENZOIC ACID, ANALGESICS | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-05-23 | — | — | US | claimed |
| US-4024279-A | Treatment of dysmenorrhea and migraine symptoms | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1977-05-17 | — | — | US | claimed |